Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation

Jump to navigation Jump to search

Supraventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Among the Different Types of Supraventricular Tachycardia

Differentiating Supraventricular Tachycardia from Ventricular Tachycardia

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples

Chest X Ray

Echocardiography

Cardiac Catheterization

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

2015 ACC/AHA Guideline Recommendations

Acute Treatment of SVT of Unknown Mechanism
Ongoing Management of SVT of Unknown Mechanism
Ongoing Management of IST
Acute Treatment of Suspected Focal Atrial Tachycardia
Acute Treatment of Multifocal Atria Tachycardia
Ongoing Management of Multifocal Atrial Tachycardia
Acute Treatment of AVNRT
Ongoing Management of AVNRT
Acute Treatment of Orthodromic AVRT
Ongoing Management of Orthodromic AVRT
Asymptomatic Patients With Pre-Excitation
Management of Symptomatic Patients With Manifest Accessory Pathways
Acute Treatment of Atrial Flutter
Ongoing Management of Atrial Flutter
Acute Treatment of Junctional Tachycardia
Ongoing Management of Junctional Tachycardia
Acute Treatment of SVT in ACHD Patients
Ongoing Management of SVT in ACHD Patients
Acute Treatment of SVT in Pregnant Patients
Acute Treatment and Ongoing Management of SVT in Older Population

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation

CDC on Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation

Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation in the news

Blogs on Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation

Directions to Hospitals Treating Supraventricular tachycardia

Risk calculators and risk factors for Supraventricular tachycardia AHA recommendations for Management of Asymptomatic Patients With Pre-Excitation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]

Overview

In asymptomatic patients with pre-excitation, the findings of abrupt loss of conduction over a manifest pathway during exercise testing in sinus rhythm or intermittent loss of pre-excitation during ECG or ambulatory monitoring are useful to identify patients at low risk of rapid conduction over the pathway. An EP study is reasonable in asymptomatic patients with pre-excitation to risk-stratify for arrhythmic events. Catheter ablation of the accessory pathway is reasonable in asymptomatic patients with pre-excitation if an EP study identifies a high risk of arrhythmic events, including rapidly conducting pre-excited AF.[1]

Management of Asymptomatic Patients With Pre-Excitation

2015 AHA recommendations for the management of asymptomatic patients with pre-excitation are described below:[1]

Class I
"1. In asymptomatic patients with pre-excitation, the findings of abrupt loss of conduction over a manifest pathway during exercise testing in sinus rhythm "(Level of Evidence: B_R ) " or intermittent loss of pre-excitation during ECG or ambulatory monitoring (Level of Evidence:C-LD ) " are useful to identify patients at low risk of rapid conduction over the pathway.
Class IIa
"1. An EP study is reasonable in asymptomatic patients with pre-excitation to risk-stratify for arrhythmic events"(Level of Evidence: B-NR ) "
"2. Catheter ablation of the accessory pathway is reasonable in asymptomatic patients with pre-excitation if an EP study identifies a high risk of arrhythmic events, including rapidly conducting pre-excited AF ("(Level of Evidence:B-NR ) "
"3. Catheter ablation of the accessory pathway is reasonable in asymptomatic patients if the presence of pre-excitation precludes specific employment (such as with pilots) "(Level of Evidence:B-NR ) "
"4. Observation, without further evaluation or treatment, is reasonable in asymptomatic patients with pre-excitation "(Level of Evidence:B-NR ) "

References

  1. 1.0 1.1 Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ; et al. (2016). "2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". J Am Coll Cardiol. 67 (13): e27–e115. doi:10.1016/j.jacc.2015.08.856. PMID 26409259.